Yoga's effect on heart failure patients' quality of life

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the impact of yoga on the quality of life and well-being of patients with chronic heart failure. It involves a randomized controlled design with two groups: one participating in yoga classes and the other engaging in storytelling workshops. Patients will attend four sessions per month for three months, with the aim of assessing improvements in emotional and physical well-being. The study is conducted at the Pitié Salpêtrière cardiology institute, focusing on patients who are stabilized and have not practiced yoga recently.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient ≥18 years old
* Chronic heart failure patient defined by: Most recent LVEF ≤50% (regardless of measurement method)
* Stabilized (last episode of acute heart failure dating back more than a month) in NYHA stage I to III dyspnoea, ambulatory, discharged from hospital for \> 1 month
* Drug treatment optimized according to the judgment of the investigator
* Ability to participate in activities as proposed (remote or face-to-face)
* Patient affiliated with a social security scheme
* Written consent to participate

Exclusion Criteria:

* Patients who have practiced yoga regularly (\> once a month) in the six months prior to selection.
* Current pregnancy / lactation
* Etiology of heart failure: hypertrophic cardiomyopathy, restrictive heart disease or severe curable valve disease
* Severe renal impairment GFR\<25ml/min/1.73 m2 or on dialysis.
* Persons subject to legal protection measures (guardianship, curatorship)
* Person not "receptive" to the practice of yoga
* Participation in intervention research

Where it's running

• Institut de Cardiologie, Centre Hospitalier Universitaire Pitié Salpêtrière (APHP), UPMC
  Paris, France Recruiting

Study contacts

• Study coordinator: Lise LEGRAND, Dr
• Email: lise.legrand@aphp.fr
• Phone: 01 42 16 30 74

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Voice-based detection of heart failure deterioration using Noah Labs Vox

  This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.

  Recruiting Noah Labs · Boston, Massachusetts · NCT07870395

• Mobile-based telemedicine to improve quality of life for chronic heart failure patients

  We’re testing whether a mobile phone–based program that sends reminders, education, and follow-up can improve quality of life for adults with chronic heart failure in Ethiopia.

  Recruiting Select College · Addis Ababa · NCT07650474

• Restoring gut bacteria in adults with chronic heart failure

  This trial tests whether replacing gut bacteria with healthy donor bacteria (intestinal microbiota transplantation) can reduce inflammation and improve function in adults with chronic heart failure.

  Recruiting Phase 1 Columbia University · New York, New York · NCT07490054

• Biventricular or left bundle branch pacing to improve heart pumping after TAVI

  This research will try whether implanting a cardiac resynchronization device (biventricular or left bundle branch pacing) shortly after TAVI helps people who develop a persistent left bundle branch block and have mildly reduced heart function (EF 35%–55%).

  Recruiting Semmelweis University Heart and Vascular Center · Budapest · NCT07434193

• Vericiguat for right‑ventricular function and heart remodeling in HFrEF

  This study will test whether adding vericiguat to usual heart‑failure treatment helps adults with stable HFrEF improve right‑ventricular function and heart remodeling over 12 months.

  Recruiting at 4 sites Phase 4 University Medical Centre Ljubljana · Izola and 3 other locations · NCT07405944

• Safety of finerenone in adults with chronic heart failure (LVEF ≥ 40%) in South Korea

  This project will see if finerenone is safe for adults in South Korea who have chronic heart failure with a left ventricular ejection fraction of 40% or higher while they take it as usual care.

  Recruiting Bayer · Multiple Locations · NCT07379840

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.